Advocates of using psychedelic drug ibogaine to treat addiction say its risks to the heart can be mitigated in a controlled study

The Kentucky Opioid Abatement Advisory Commission held its first public hearing Monday, July 17, to discuss funding development of an opioid-use disorder treatment using the psychedelic drug ibogaine with some of the…

Continue ReadingAdvocates of using psychedelic drug ibogaine to treat addiction say its risks to the heart can be mitigated in a controlled study